About Vektor Medical
Vektor Medical is advancing care for arrhythmia patients by unlocking insights contained in standard ECG data through artificial intelligence. The company's flagship product, vMap, is an FDA-cleared and CE-marked arrhythmia analysis tool that provides rich 4-chamber cardiac insights from non-invasive ECG mapping. vMap addresses a global health crisis where cardiac arrhythmias cause 10% of global deaths and over 25% of adults over 40 develop serious arrhythmias. The platform is indicated for seven arrhythmias and two pacing types, including atrial and ventricular tachycardia, fibrillation, pacing, premature complexes (PACs and PVCs), and orthodromic atrioventricular reentrant tachycardia. Clinical studies have demonstrated that vMap use is associated with significant reductions in procedure time, improved arrhythmia-free survival rates, and better outcomes in unstable ventricular tachycardia cases. The technology uses forward-solution computational ECG mapping to accurately identify arrhythmia and pacing locations, providing clinically actionable spatial accuracy that supports catheter-based and noninvasive arrhythmia therapies. Vektor Medical serves electrophysiologists and cardiac care teams in health systems, helping them streamline workflows and reduce procedural burden without compromising clinical outcomes.
Mission & Story
Mission
We are advancing care for arrhythmia patients by unlocking insights contained in a standard ECG
Founding Story
Vektor Medical was co-founded by Dr. David Krummen (professor of medicine at UC San Diego and director of electrophysiology at VA San Diego Healthcare System), Dr. Gordon Ho (assistant professor of medicine at UC San Diego with over 10 years experience in computational modeling), Dr. Andrew McCulloch (Distinguished Professor of Bioengineering and Medicine at UC San Diego), and Chris Villongco, Ph.D. (CTO with over a decade of experience in computational modeling and high-performance computing). The founding team pioneered the application of patient-specific computational models of cardiac electrophysiology to address complex clinical challenges in arrhythmias.
Clinical Focus
Medical conditions and clinical areas addressed by Vektor Medical.
Who It Serves
Milestones & Awards
Recent Milestones
FDA clearance and CE mark approval for vMap. Multiple peer-reviewed clinical studies published demonstrating procedural efficiency improvements and clinical outcomes. Expanded indications to cover 7 arrhythmias and 2 pacing types.
Key Partnerships
Company Details
- Headquarters
- San Diego, CA, USA
- Employees
- 11-50
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.